Genetics, Gut Health, and Advanced Liver Treatment Converge
Today’s healthcare news highlights the converging fields of longevity research and gastroenterology, underscoring how fundamental aspects of biology—from genetics to exercise—determine long-term healthspan. New data suggest that our innate genetic code plays a substantially larger role in determining individual lifespan variability than previously thought, accounting for around 50% of the difference, once external mortality factors are removed. This finding, while not diminishing the importance of lifestyle, reinforces the scientific effort to identify specific longevity genes for therapeutic targeting. Simultaneously, research continues to define the modifiable factors within our control, notably through gastrointestinal function, which is acutely responsive to diet, specific supplements, and physical activity. Clinical gastroenterology is also advancing, with a phase 3 study providing final efficacy data for a combination therapy that significantly improves overall survival for patients with unresectable hepatocellular carcinoma (HCC). This diverse scientific progress confirms that longevity medicine must incorporate sophisticated pharmacological options alongside a focus on foundational lifestyle interventions.
These findings carry important implications for clinical practice, necessitating a balanced approach in patient communication. Doctors must now weigh the newly quantified genetic component of longevity against established, modifiable factors like diet and exercise, which remain crucial for healthspan improvement. Furthermore, the success of advanced combination therapies in liver cancer provides a necessary reminder of the continued impact of targeted oncology in improving survival outcomes for aggressive gastrointestinal diseases. For both clinicians and patients, the message is clear: while genetics set a baseline, proactive lifestyle choices and modern medicine offer significant leverage in extending healthy, disease-free years.
Key Stories Today
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study
News Brief: Final phase 3 data confirm that the combination of camrelizumab (PD-1 inhibitor) and rivoceranib (VEGFR2 inhibitor) significantly improves overall survival in first-line unresectable HCC versus sorafenib.
Summary: The CARES-310 phase 3 trial provided the final analysis of overall survival (OS) data for the combination immunotherapy and anti-angiogenic treatment, camrelizumab plus rivoceranib, in patients with unresectable hepatocellular carcinoma (HCC). The study reported a median OS of 23.8 months for the combination group, compared to 15.2 months for patients receiving sorafenib monotherapy, equating to a 36% reduction in the risk of death (Hazard Ratio 0.64). Median progression-free survival was also prolonged at 5.6 months versus 3.7 months.
The clinical relevance of these findings is substantial, supporting the combination regimen as a new standard first-line treatment option for advanced HCC. However, clinicians must consider the safety profile. Grade 3 or 4 treatment-related adverse events were reported in 81% of the combination group versus 54% in the sorafenib group. The most common serious events in the combination arm were hypertension (38%) and increased liver enzymes (increased aspartate aminotransferase was 17%). These toxicity profiles underscore the need for diligent monitoring of cardiovascular and hepatic function when initiating this combination therapy.
Source: https://pubmed.ncbi.nlm.nih.gov/41308676/
The quest for genetic determinants of human longevity: challenges and insights
News Brief: Recent research suggests that the heritability of human lifespan is approximately 50%, higher than prior estimates. This highlights that intrinsic biological ageing, driven by genetics, is a major factor in determining individual longevity.
Summary: While the source abstract discusses the historical challenge of identifying genetic determinants of longevity, citing early estimates of heritability around 25%, current methods adjusting for external causes of death paint a different picture. When deaths from infectious disease, accidents, or violence (extrinsic mortality) are excluded, mathematical models show that genetic factors account for approximately 50% of the variation in human lifespan. This finding is consistent with heritability estimates seen in laboratory animals and complex human traits.
The clinical relevance lies in validating the pursuit of gene variants that protect against age-related decline, encouraging further research into biological ageing mechanisms. For physicians, while 50% of longevity may be genetically determined, the other half remains attributable to environmental factors, lifestyle, and randomness. Limitations include the fact that heritability is context-specific; the estimate is based on studies of homogeneous twin populations in countries like Sweden and Denmark, meaning the genetic component may be smaller in more diverse populations with wider environmental and socioeconomic disparities.
Source: https://user.demogr.mpg.de/jwv/pdf/Nature%20Reviews%20Genetics%207(2006)%20436-448.pdf
Tempeh extract may extend lifespan, for tiny worms at least
News Brief: A study utilising C. elegans nematodes found that extracts from tempeh, a fermented soybean product, significantly extended their mean lifespan by up to 45%. The longevity effect appears linked to the MAPK signalling pathway and enhanced resistance to oxidative stress.
Summary: This new research investigated the anti-ageing effects of tempeh, a traditional Indonesian fermented soybean food, using the model organism Caenorhabditis elegans. Researchers found that treating the nematodes with tempeh extract at an optimal concentration (100 µg/ml) increased their mean lifespan by 45%. The study indicated that tempeh promotes healthy ageing by enhancing oxidative stress resistance and improving healthspan during the middle stages of life.
Mechanistically, the lifespan extension was dependent on the PMK-1–SKN-1 pathway, which suggests a linkage to the Mitogen-Activated Protein Kinase (MAPK) pathway, a known regulator of stress response and longevity, and notably independent of caloric restriction.
The clinical relevance for human longevity is currently low, as the finding is derived purely from an invertebrate model. While the study highlights the potential of fermented foods as functional sources for promoting healthy ageing, extrapolation of a 45% increase in lifespan from nematodes to humans is impossible. The primary limitation is the fundamental biological difference between the model organism and mammalian systems, meaning further research in human or higher-order models is required before any dietary recommendations based on these findings can be made.
Source: https://www.nutraingredients.com/Ingredients/Polyphenols/
Exercise a Key Ally in Gut Health and GI Disease Prevention
News Brief: A systematic review confirms that regular moderate-intensity exercise positively modulates the gut microbiome, reduces systemic inflammation, and lowers the risk for multiple gastrointestinal diseases, including IBS.
Summary: A comprehensive systematic review evaluated the bidirectional relationship between physical activity and gastrointestinal (GI) health. The analysis concluded that moderate-intensity exercise, such as walking or cycling, is a valuable intervention for improving overall GI function and preventing disease. Benefits are thought to be mediated through several mechanisms: enhanced intestinal motility, reduced systemic inflammation, and improved integrity of the gut barrier. Crucially, regular activity increases the diversity and abundance of beneficial gut bacteria, contributing to better digestion and reduced symptoms associated with Irritable Bowel Syndrome (IBS) and constipation.
However, the review also highlights limitations regarding exercise type and intensity. High-intensity or prolonged activities, common in endurance sports like ultra-marathons, can exacerbate GI symptoms such as nausea, abdominal pain, and diarrhoea. This is often due to splanchnic hypoperfusion (reduced blood flow to the intestines) and increased intestinal permeability. Clinicians should therefore promote moderate, sustainable exercise for general GI health, but advise caution and personalised dietary strategies for athletes engaging in strenuous, high-duration physical activity to mitigate potential GI distress.
Source: https://www.medscape.com/index/list_12208_0
What’s the Best Diet for a Longer, Healthier Life?
News Brief: Evidence strongly supports that dietary patterns, particularly the Mediterranean diet, are vital for longevity, significantly reducing overall mortality rates and chronic inflammation. Lifestyle modifications, not just genetics, remain the most influential factor in extending healthspan.
Summary: A review focusing on nutrition and longevity reaffirmed that lifestyle choices, rather than quick fixes or single supplements, have the largest impact on healthspan and life expectancy. The Mediterranean diet pattern is identified as one of the most extensively studied and scientifically supported approaches for longevity, linked to a 25% reduction in overall mortality rates. This benefit is attributed to the high intake of fruits, vegetables, whole grains, legumes, and healthy fats like olive oil, which deliver antioxidant and anti-inflammatory benefits.
Experts emphasise that nutrient-dense foods reduce oxidative stress, decrease inflammation, and help maintain a healthy gut microbiome, all critical mechanisms underpinning long-term health. Other key modifiable factors cited for improving longevity include maintaining a healthy weight, regular physical activity (at least 150 minutes per week of moderate intensity), and avoiding smoking.
The main limitation is that the term “longevity diet” is broad; however, the consensus from health scientists is to focus on holistic, sustainable dietary patterns rather than isolating specific nutrients. Genetic makeup only accounts for a quarter to half of lifespan variation, leaving lifestyle and environment as powerful determinants for improving the quality of life in later years.
Source: https://www.healthline.com/health-news/best-foods-longer-healthier-life-research